Your session is about to expire
← Back to Search
Goal Management Training in Individuals With PTSD
N/A
Waitlist Available
Led By Ruth A. Lanius, MD, PhD
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if Goal Management Training (GMT) can help adults with PTSD, including COVID-19 frontline workers, improve their thinking skills. GMT teaches strategies for better goal and task management. Participants will either start GMT right away or wait for a few months before beginning the program. GMT is designed to improve attention and thinking skills.
Eligible Conditions
- Post Traumatic Stress Disorder
- Cognitive Impairment
- PTSD
- Dementia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Clinician Administered PTSD Scale (CAPS) score from baseline to post-treatment assessment
Change in Clinician Administered PTSD Scale (CAPS) score from post-treatment to 3-month follow-up assessment
Change in Difficulties in Emotion Regulation Scale (DERS) score from baseline to post-treatment assessment
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Goal Management Training (GMT)Experimental Treatment1 Intervention
Participants in this arm will attend 9 weekly, 2-hour group GMT appointments.
Group II: Wait ListActive Control1 Intervention
Participants in this arm will receive no treatment for approximately 21 weeks (at which point, they will be offered the same, standard GMT treatment).
Find a Location
Who is running the clinical trial?
Lawson Health Research InstituteLead Sponsor
681 Previous Clinical Trials
431,340 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,392 Previous Clinical Trials
26,529,445 Total Patients Enrolled
FDC FoundationOTHER
2 Previous Clinical Trials
11 Total Patients Enrolled
Ruth A. Lanius, MD, PhDPrincipal InvestigatorLawson Research Institute